Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01439152
Brief Title: Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

First Submitted : September 1, 2011
First Submitted that Met QC Criteria : September 22, 2011
First Posted : September 23, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : July 6, 2021
Last Update Posted : July 9, 2021